Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

[Clonal relatedness of bla(OXA-58)--carrying Acinetobacter baumannii clinical isolates].

Wang XH, Zong ZY, Lü XJ.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 May;44(3):405-9. Chinese.

PMID:
23898523
2.

Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.

Lee MH, Chen TL, Lee YT, Huang L, Kuo SC, Yu KW, Hsueh PR, Dou HY, Su IJ, Fung CP.

J Microbiol Immunol Infect. 2013 Dec;46(6):419-24. doi: 10.1016/j.jmii.2012.08.006. Epub 2012 Sep 24.

3.

[Investigation of OXA type beta-lactamases and PFGE patterns in Acinetobacter baumannii strains resistant to carbapenems].

Keyik S, Arslan U, Türk Dağı H, Seyhan T, Fındık D.

Mikrobiyol Bul. 2014 Oct;48(4):556-65. Turkish.

4.

Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.

Lee HY, Chang RC, Su LH, Liu SY, Wu SR, Chuang CH, Chen CL, Chiu CH.

Int J Antimicrob Agents. 2012 Aug;40(2):163-7. doi: 10.1016/j.ijantimicag.2012.04.018. Epub 2012 Jun 27.

PMID:
22743015
5.

Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.

Lee YT, Fung CP, Wang FD, Chen CP, Chen TL, Cho WL.

J Microbiol Immunol Infect. 2012 Feb;45(1):43-51. doi: 10.1016/j.jmii.2011.09.020. Epub 2011 Dec 14.

6.

A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.

Héritier C, Dubouix A, Poirel L, Marty N, Nordmann P.

J Antimicrob Chemother. 2005 Jan;55(1):115-8. Epub 2004 Dec 8.

PMID:
15590718
7.

Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.

Zander E, Chmielarczyk A, Heczko P, Seifert H, Higgins PG.

J Antimicrob Chemother. 2013 Feb;68(2):308-11. doi: 10.1093/jac/dks382. Epub 2012 Sep 26.

PMID:
23014718
8.

Characterization of bla(OxA-23) gene regions in isolates of Acinetobacter baumannii.

Wang D, Yan D, Hou W, Zeng X, Qi Y, Chen J.

J Microbiol Immunol Infect. 2015 Jun;48(3):284-90. doi: 10.1016/j.jmii.2014.01.007. Epub 2014 Mar 24.

9.

Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.

Ben RJ, Yang MC, Hsueh JC, Shiang JC, Chien ST.

Int J Antimicrob Agents. 2011 Nov;38(5):403-8. doi: 10.1016/j.ijantimicag.2011.05.014. Epub 2011 Aug 26.

PMID:
21871784
10.

Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.

Peymani A, Higgins PG, Nahaei MR, Farajnia S, Seifert H.

Int J Antimicrob Agents. 2012 Jun;39(6):526-8. doi: 10.1016/j.ijantimicag.2012.02.014. Epub 2012 Apr 20.

PMID:
22521767
11.

Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.

Lu PL, Doumith M, Livermore DM, Chen TP, Woodford N.

J Antimicrob Chemother. 2009 Apr;63(4):641-7. doi: 10.1093/jac/dkn553. Epub 2009 Jan 31.

PMID:
19182237
12.

Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne bla(OXA-72) in Taiwan.

Kuo SC, Yang SP, Lee YT, Chuang HC, Chen CP, Chang CL, Chen TL, Lu PL, Hsueh PR, Fung CP.

BMC Infect Dis. 2013 Jul 13;13:319. doi: 10.1186/1471-2334-13-319.

13.

Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China.

Ning NZ, Liu X, Bao CM, Chen SM, Cui EB, Zhang JL, Huang J, Chen FH, Li T, Qu F, Wang H.

BMC Infect Dis. 2017 Jan 5;17(1):14. doi: 10.1186/s12879-016-2110-1.

14.
15.

Molecular characteristics and resistant mechanisms of imipenem-resistant Acinetobacter baumannii isolates in Shenyang, China.

Zhang JP, Zhu W, Tian SF, Chu YZ, Chen BY.

J Microbiol. 2010 Oct;48(5):689-94. doi: 10.1007/s12275-010-0137-3. Epub 2010 Nov 3.

PMID:
21046349
16.

Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.

Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y.

Antimicrob Agents Chemother. 2007 Nov;51(11):4022-8. Epub 2007 Sep 10.

17.

Genetic Characterization of ST195 and ST365 Carbapenem-Resistant Acinetobacter baumannii Harboring blaOXA-23 in Guangzhou, China.

Zhou Y, Wu X, Zhang X, Hu Y, Yang X, Yang Z, Wang M.

Microb Drug Resist. 2015 Aug;21(4):386-90. doi: 10.1089/mdr.2014.0183. Epub 2015 Jan 20.

PMID:
25602500
18.

A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.

Karah N, Giske CG, Sundsfjord A, Samuelsen Ø.

Microb Drug Resist. 2011 Dec;17(4):545-9. doi: 10.1089/mdr.2011.0089. Epub 2011 Aug 10.

PMID:
21830948
19.

IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.

Koh TH, Sng LH, Wang GC, Hsu LY, Zhao Y.

J Antimicrob Chemother. 2007 Apr;59(4):627-32. Epub 2007 Feb 6.

PMID:
17284537
20.

High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.

Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J.

Clin Microbiol Infect. 2007 Dec;13(12):1192-8. Epub 2007 Sep 10.

Supplemental Content

Support Center